We therefore sought to validate the potential of IL-11 as a diagnostic biomarker in paired plasma and serum of primary NSCLC patients undergoing surgical treatment against normal volunteers in Singapore. The gene discussed is IL11; the disease is non-small cell lung carcinoma.